APA (7th ed.) Citation

Wang, Y., Parlevliet, E. T., Geerling, J. J., van der Tuin, S. J. L., Zhang, H., Bieghs, V., . . . Rensen, P. C. N. (2014). Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration. British Journal of Pharmacology, 171(4), 723. https://doi.org/10.1111/bph.12490

Chicago Style (17th ed.) Citation

Wang, Y., et al. "Exendin-4 Decreases Liver Inflammation and Atherosclerosis Development Simultaneously by Reducing Macrophage Infiltration." British Journal of Pharmacology 171, no. 4 (2014): 723. https://doi.org/10.1111/bph.12490.

MLA (9th ed.) Citation

Wang, Y., et al. "Exendin-4 Decreases Liver Inflammation and Atherosclerosis Development Simultaneously by Reducing Macrophage Infiltration." British Journal of Pharmacology, vol. 171, no. 4, 2014, p. 723, https://doi.org/10.1111/bph.12490.